In acral melanomas there is a relationship between PTEN loss and amplification of the AMPK-related kinase NUAK2; importantly, in these melanomas, the presence of both PTEN loss and NUAK2 amplification was associated with poor prognosis [63]. The gene discussed is NUAK2; the disease is acral lentiginous melanoma.